Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study von Alva, Ajjai S, Mangat, Pam K, Garrett-Mayer, Elizabeth, Halabi, Susan, Hansra, Damien, Calfa, Carmen J, Khalil, Maged F, Ahn, Eugene R, Cannon, Timothy L, Crilley, Pamela, Fisher, Julie G, Haslem, Derrick S, Shrestha, Sagun, Antonelli, Kaitlyn R, Butler, Nicole L, Warren, Sasha L, Rygiel, Andrew L, Ranasinghe, Shamika, Bruinooge, Suanna S, Schilsky, Richard L

Volltext

Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate von Mackay, Christine B., Antonelli, Kaitlyn R., Bruinooge, Suanna S., Saint Onge, Jarron M., Ellis, Shellie D.

Volltext

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study von Al Baghdadi, Tareq, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Rich, Patricia, Ahn, Eugene R., Chai, Seungjean, Rygiel, Andrew L., Osayameh, Olufunlayo, Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Abstract CT146: Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with FLT-3 alterations: Results from the Targeted Agent and Profiling Utilization Registry... von Alvarez, Ricardo H., Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Baghdadi, Tareq Al, Ahn, Eugene R., Chai, Seungjean, Rygiel, Andrew L., Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF mutations: Results from the Targete... von Fisher, Julie, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Alvarez, Ricardo H., Cannon, Timothy L., Crilley, Pamela, Pollock, Theodore, Baghdadi, Tareq Al, Cotta, Jared A., Rygiel, Andrew L., Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study von Ahn, Eugene R, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Dib, Elie G., Haggstrom, Daniel Ernest, Alguire, Kathryn B., Alvarez, Ricardo H., Calfa, Carmen Julia, Cannon, Timothy Lewis, Crilley, Pamela A., Gaba, Anu G., Marr, Alissa S., Sangal, Ashish, Thota, Ramya, Antonelli, Kaitlyn R., Islam, Samiha, Rygiel, Andrew Lawrence, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry... von Alva, Ajjai Shivaram, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Alvarez, Ricardo H., Calfa, Carmen Julia, Khalil, Maged F., Ahn, Eugene R, Cannon, Timothy Lewis, Crilley, Pamela A., Fisher, Julie Gottlieb, Haslem, Derrick S., Shrestha, Sagun, Antonelli, Kaitlyn R., Butler, Nicole L., Warren, Sasha L., Rygiel, Andrew Lawrence, Ranasinghe, Shamika, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Palbociclib (P) in patients (Pts) with pancreatic cancer (PC) and gallbladder or bile duct cancer (GBC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utili... von Al Baghdadi, Tareq, Halabi, Susan, Garrett-Mayer, Elizabeth, Mangat, Pam K., Ahn, Eugene R, Sahai, Vaibhav, Alvarez, Ricardo H., Kim, Edward S., Yost, Kathleen J, Guo, Kuo, Rygiel, Andrew Lawrence, Antonelli, Kaitlyn R., Butler, Nicole L., Bruinooge, Suanna S., Schilsky, Richard L.

Volltext